Loading insider details...
Beta
Latest Form 4 (Dec 19, 2025): Grant/Award of 54,000 ARCT shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Dec 19, 2025 | Arcturus Therapeutics Holdings Inc. (ARCT) | Grant/Award | 54,000 | n/a |
| Dec 18, 2024 | Arcturus Therapeutics Holdings Inc. (ARCT) | Grant/Award | 60,000 | n/a |
| Oct 17, 2024 | Arcturus Therapeutics Holdings Inc. (ARCT) | Sale | 12,000 | $249.1K |
| Jun 7, 2024 | Arcturus Therapeutics Holdings Inc. (ARCT) | Sale | 114 | $5.1K |
| Jun 4, 2024 | Arcturus Therapeutics Holdings Inc. (ARCT) | Sale | 26,000 | $1.04M |
| Mar 27, 2024 | Arcturus Therapeutics Holdings Inc. (ARCT) | Sale | 17,435 | $610.6K |
| Mar 21, 2024 | Arcturus Therapeutics Holdings Inc. (ARCT) | Sale | 8,565 | $299.8K |
| Dec 20, 2023 | Arcturus Therapeutics Holdings Inc. (ARCT) | Grant/Award | 125,000 | n/a |
| Nov 3, 2023 | Arcturus Therapeutics Holdings Inc. (ARCT) | Sale | 5,000 | $93.6K |
| Oct 4, 2023 | Arcturus Therapeutics Holdings Inc. (ARCT) | Sale | 5,000 | $128.1K |